MTOR and Merkel cell skin cancer: A further indication of the importance of PI3K/AKT/mTOR Pathway is that MLN0128, a dual mTORC1/mTORC2 inhibitor, effectively suppressed MCC cell growth both in vitro and in vivo using mouse xenograft models [55].